Table 2 Univariate and multivariate analysis for in-hospital Adverse outcome in patients with intermediate risk pulmonary embolism
Univariate analysis | p | OR (95% CI) | Multivariate analysis | p | OR (95% CI) |
|---|---|---|---|---|---|
SaO2 < 90% | 0.029 | 1.135 (1.135–10.283) | SaO2 < 90% | 0.024 | 5.343(1.241–23.008) |
RV/LV ratio | 0.015 | 4.133 (1.323–12.909) | RV/LV ratio | 0.036 | 7.429 (1.145–48.209) |
Syncope | 0.031 | 4.375 (1.140–16.785) | Syncope | 0.013 | 12.309(1.702–89.032) |
NTW in V1-V3 | 0.005 | 4.731 (1.590–14.080) | NTW in V1-V3 | 0.026 | 5.617 (1.228–25.683) |
Intermediate high risk | 0.019 | 3.840 (1.242–11.873) |  |  |  |
BNP | 0.022 | 1.001 (1.000–1.003) |  |  |  |
WBC, × 109/L | 0.020 | 1.145 (1.022–1.282) | WBC, × 109/L | 0.017 | 1.212 (1.035–1.419) |